Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Colby

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Mayo Clinic Proceedings|June 9, 2012
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general populationAngela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Blood|January 31, 2009
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significanceCeline M Vachon, Robert A Kyle, Terry M Therneau, et al.
Journal of Affective Disorders|October 22, 2016
A genome wide association study suggests the association of muskelin with early onset bipolar disorder: Implications for a GABAergic epileptogenic neurogenesis modelMalik Nassan, Qingqin Li, Paul E Croarkin, et al.
Bipolar Disorders|March 3, 2016
Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated body mass indexAlfredo B Cuellar-Barboza, Stacey J Winham, Susan L McElroy, et al.
Clinical Pharmacology and Therapeutics|July 7, 2020
Mood-Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome-Wide Association StudyAda Man-Choi Ho, Brandon J Coombes, Thanh Thanh L Nguyen, et al.
British Journal of Haematology|May 26, 2012
Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myelomaAlexandra J Greenberg, S Vincent Rajkumar, Dirk R Larson, et al.
Lancet (London, England)|May 18, 2010
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort studyAngela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Bipolar Disorders|February 6, 2021
Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort studyMehak Pahwa, Boney Joseph, Nicolas A Nunez, et al.
Blood|August 28, 2010
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical featuresShaji Kumar, Angela Dispenzieri, Jerry A Katzmann, et al.
Addiction Biology|August 7, 2012
Association of GATA4 sequence variation with alcohol dependenceVictor M Karpyak, Stacey J Winham, Joanna M Biernacka, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Mayo Clinic Proceedings|June 9, 2012
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general populationAngela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Blood|January 31, 2009
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significanceCeline M Vachon, Robert A Kyle, Terry M Therneau, et al.
Journal of Affective Disorders|October 22, 2016
A genome wide association study suggests the association of muskelin with early onset bipolar disorder: Implications for a GABAergic epileptogenic neurogenesis modelMalik Nassan, Qingqin Li, Paul E Croarkin, et al.
Bipolar Disorders|March 3, 2016
Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated body mass indexAlfredo B Cuellar-Barboza, Stacey J Winham, Susan L McElroy, et al.
Clinical Pharmacology and Therapeutics|July 7, 2020
Mood-Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome-Wide Association StudyAda Man-Choi Ho, Brandon J Coombes, Thanh Thanh L Nguyen, et al.
British Journal of Haematology|May 26, 2012
Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myelomaAlexandra J Greenberg, S Vincent Rajkumar, Dirk R Larson, et al.
Lancet (London, England)|May 18, 2010
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort studyAngela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Bipolar Disorders|February 6, 2021
Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort studyMehak Pahwa, Boney Joseph, Nicolas A Nunez, et al.
Blood|August 28, 2010
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical featuresShaji Kumar, Angela Dispenzieri, Jerry A Katzmann, et al.
Addiction Biology|August 7, 2012
Association of GATA4 sequence variation with alcohol dependenceVictor M Karpyak, Stacey J Winham, Joanna M Biernacka, et al.
Pageof 3